Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study.

1 Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, L-4354 Luxembourg;

2 Competence Center for Methodology and Statistics, Luxembourg Institute of Health. Strassen L-1445 Luxembourg;

3 Department of Microbiology, Laboratoire national de santé, Dudelange, L-3555, Luxembourg;

4 Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg;

1 Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, L-4354 Luxembourg;

5 Integrated Biobank of Luxembourg (IBBL), Dudelange, L-3555 Luxembourg;

6 Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg;

7 Luxembourg Institute of Health;

8 Department of Neurology, Centre Hospitalier de Luxembourg, Luxembourg, L-1210 Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg;

6 Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg;

9 Department of Neurology, Centre Hospitalier de Luxembourg, Luxembourg, L-1210 Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg;

9 Department of Neurology, Centre Hospitalier de Luxembourg, Luxembourg, L-1210 Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg;

6 Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg;

10 Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg;

11 Department of Neurology, Centre Hospitalier de Luxembourg, Luxembourg, L-1210 Transversal Translational Medicine, Luxembourg Institute of Health, Strassen, Luxembourg;

9 Department of Neurology, Centre Hospitalier de Luxembourg, Luxembourg, L-1210 Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg;

12 Population Health Department, Luxembourg Institute of Health. Strassen L-1445 Luxembourg;

12 Population Health Department, Luxembourg Institute of Health. Strassen L-1445 Luxembourg;

13 Transversal Translational Medicine, Luxembourg Institute of Health, Strassen, Luxembourg;

4 Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-Belval, Luxembourg;

14 Clinical and Epidemiological Investigation Center (CIEC), Luxembourg Institute of Health. Strassen L-1445 Luxembourg;

12 Population Health Department, Luxembourg Institute of Health. Strassen L-1445 Luxembourg;

15 Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, L-4354 Luxembourg Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis, University of Southern Denmark, Odense C, Denmark;

16 Transversal Translational Medicine, Luxembourg Institute of Health, Strassen, Luxembourg Department of Neurology, Centre Hospitalier de Luxembourg, Luxembourg, L-1210 Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB)